MicroPort NeuroScientific Revenue
Medical Equipment Manufacturing • 
Pudong, Shanghai, China • 21-50 Employees
MicroPort NeuroScientific revenue & valuation
| Annual revenue | $2,309,985 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $7,400,000 |
| Total funding | $150,000,000 |
Key Contacts at MicroPort NeuroScientific
Rtn. Aria Ohri
Regional Sales Director Southeast Asia & South Asia
Yixin Wang
Director Of Business Operations
Satoshi Yoshida
Sales Director Of North Asia
Yiman Lyu
R&D Director
Susan （Xin） Yuan
International Marketing Director
Zaoli Wu
Human Resources Director
Yan Cherry
Director Of International Regulatory And Clinical Affairs
Company overview
| Headquarters | Pudong, Shanghai, China |
| Phone number | +862138954600 |
| Websites | |
| NAICS | 3391 |
| Employees | 21-50 |
| Socials |
MicroPort NeuroScientific Email Formats
MicroPort NeuroScientific uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@microport.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@microport.com | 66.7% |
{first name}.{last name} | john.doe@microport.com | 33.3% |
About MicroPort NeuroScientific
MicroPort NeuroScientific（Formerly known as “MicroPort NeuroTech”), as a member of Microport Scientific Corporation (00853.HK, MicroPort), has been researching and developing industry leading neuro-interventional medical devices since 2002. We are dedicated to providing universal stroke treatment solutions to patients and physicians worldwide. Since the approval of our first product - APOLLO™ intracranial stent system in 2004, we have been developing a comprehensive product portfolio which covers three major neurovascular disease areas, specifically Hemorrhagic Stroke, Intra and Extracranial Atherosclerotic Stenosis, and Acute Ischemic Stroke. As of Aug 2024, we had 21 products approved by NMPA, and 4 products admitted to the NMPA’s Innovative Medical Device Special Review and Approval procedure (known as the “Green Path”). Our products are available in over 3,000 hospitals nationwide, providing safe and effective stroke solutions for more than 420,000 patients accumulatively. Meanwhile, we have a leading global strategy and international expansion. a total of 8 products of the Group were approved for marketing in 23 overseas countries or regions. Headquartered in Shanghai Zhangjiang Science City, NeuroTech employs over 400 people worldwide. In our pursuit of excellence, we aspire to improve the lives of patients, physicians and our employees, and to create innovative solutions for neurovascular stroke disorders. Together, our efforts will continue to impact the health and well-being of people globally. For more information, please visit https://www.microportneuro.com/
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
MicroPort NeuroScientific has 19 employees across 6 departments.
Departments
Number of employees
Funding Data
Explore MicroPort NeuroScientific's funding history, including investment rounds, total capital raised, and key backers.
MicroPort NeuroScientific Tech Stack
Discover the technologies and tools that power MicroPort NeuroScientific's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
Security
Ecommerce
JavaScript frameworks
Security
Miscellaneous
JavaScript libraries
Ecommerce
JavaScript libraries
CMS
Performance
Spain
United Kingdom
United Arab EmiratesFrequently asked questions
4.8
40,000 users
